Susanne Posel
Occupy Corporatism
January 5, 2013
According to a new study, an estimated 3 million people with a body mass index (BMI) which classifies them as overweight are at less risk of dying than those who are of average or “normal” weight. The mythology surrounding the link between a person’s BMI and mortality rate is shattered with this new finding.
Experts say that those who are clinically overweight are not necessarily going to suffer from diseases traditionally correlated with extra pounds. It still remains the talk of doctors that obesity must be avoided; yet this study and others like it show that conceptions when placed against scientific data are not always parallel.
Convention still ties 30% of those deemed obese as at risk for an early death. The problem lies in the determination of obesity and overweight. Medical doctors still disagree as to where the line is drawn.
The study also finds that being slightly overweight is good for the body, which is at odds with the trending in social circles. Katherine Flegal, senior researcher at the Center for Disease Control and Prevention’s National Center for Health Statistics reveals that: “For people with a medical condition, survival is slightly better for people who are slightly heavier. Maybe heavier people present to the doctor earlier, or get screened more often. Heavier people may be more likely to be treated according to guidelines, or fat itself may be cardioprotective, or someone who is heavier might be more resilient and better able to stand a shock to their system.”
BMI has been the defining parameter in the past along with the actual weight of the person. Yet overweight individuals do not preform according to the medical communities expectations when scientific research is conducted and examined.
The causational attribute to being overweight and pre-mature death is now being reevaluated with the findings of this study.
The battle of the bulge in 2012 has centered on international calls for monitoring of the increasing levels of “fatness” worldwide and the impact such weight gain has on global resources. They contend that over-weight people are likening to an extra billion humans born on the planet.
Researchers at the BMC Public Health have published a study stating that this trend is not sustainable. They contend a new social meme concerning consumption, weight and population growth called “globesity” must be introduced to combat this new problem.
Ian Roberts, professor and co-author of the study explains: “When people think about environmental sustainability, they immediately focus on population. Actually, when it comes down to it – it’s not how many mouths there are to feed, it is how much flesh there is on the planet.”
The UN report entitled, “Global Status Report on Noncommunicable Diseases” mandates that “national and global monitoring and surveillance” for reversing the epidemic of obesity is necessary to “address the epidemic”.
The World Health Organization (WHO) complains about the lack of “surveillance systems and monitoring” of over-weight people are not “integrated into national health information systems”. They demand that obese people be surveilled by the healthcare industry and governmental agencies to reduce “behavioral and metabolic risk factors” in low-income communities.
WHO asserts that “strengthening surveillance is a priority at the national and global levels.” They also recommend “interventions” by healthcare professionals and governments as long as they are “cost effective”.
Along with controlling the diet of the general public, WHO asserts that vaccinations against Hepatitis B and the HPV immunization will assist in lowering the weight problem and other all health of the public.
A study entitled “BLOOM-DM (Behavioral Modification and Lorcaserin for Obesity and Overweight Management in Diabetes Mellitus)”, recorded the effects of lorcaserin, an obesity drug.
This study was published in The Obesity Journal (TOS). Patrick O’Neil, president of TOS and lead researcher concluded that there is a very “meaningful difference in weight loss for this population. Importantly, the patients on active medication also showed much greater improvement on a key measure of blood glucose control.”
The TOS is a research organization involved in many different experimental drug therapies to reduce the public’s obesity problem. They create information in tandem with the medical community to “educate” the public as to how to mitigate their issues with weight.
Dr. Robert Kushner, former president of TOS says that “if approved by the FDA, lorcaserin will provide an additional tool to fill the gap between lifestyle intervention alone at one end and bariatric surgical intervention at the other end.”
The UN blames “rapid unplanned urbanization” and the “globalization of unhealthy lifestyles” as the culprits of the obesity epidemic. The UN also declares that the cost of overweight and obese individuals in a drain on our global economy; and a burden indicative of large, affluent societies, like America.
A new propaganda study published in the Journal of Animal Science and Biotechnology, claims that vaccines are the answer to the chemical and psychological issues that surround obesity. The co-author of the study was also the president and chief scientific officer of a company called Braasch Biotech LLC. Braasch Biotech LLC, which specializes in the development of human and animal vaccines. Essentially, by inhibiting natural hormones, researchers hope to stop people from eating.
Big Pharma have created all-in-one vaccines before, i.e. the universal flu shot that was meant to entice the public back into a regular immunization schedule. However, this is not just about poisoning the public through vaccinations; the drug corporations see the obesity market as an untapped monetary resource – as one executive explained: “Can you imagine the potential for vaccines?”
Scientists assert that somatostatin, a peptide hormone, inhibits the action of growth hormone and insulin-like growth factor, both of which increase metabolism and result in weight loss. The vaccine would modify somatostatin by engineering so that the chemical inhabitation is removed and antibodies are created against somatostatin.
Because somatostatin is secreted in the digestive system, the hormone would eventually be carried to the brain where it would have a great likelihood of interacting with the chemical makeup of the brain and thereby have an encompassing psychological reaction.
Add This to Technorati Faves
